Favuza (Favipiravir) 200mg Tab 30s

Description

Favuza (Favipiravir) 200mg Tablet – 30s

Description:

Favuza is a brand of favipiravir, an antiviral medication used primarily for the treatment of mild to moderate COVID-19 in adults. It works by inhibiting the RNA-dependent RNA polymerase enzyme, which is essential for the replication of the SARS-CoV-2 virus. By interfering with viral replication, favipiravir helps reduce the severity and duration of the illness.

Dosage and Administration:

• Initial Dose: 1600 mg (8 tablets) twice daily on the first day.
• Maintenance Dose: 600 mg (3 tablets) twice daily from the second day onward.
• Duration: Typically administered for 5 days, but the duration may vary based on clinical response and physician’s judgment.

Administration Tips:

• Take tablets with or without food.
• Swallow tablets whole with water; do not crush or chew.
• Ensure adherence to the prescribed dosage schedule.

Common Side Effects:

• Gastrointestinal issues such as nausea, vomiting, and diarrhea.
• Elevated liver enzymes (transaminitis).
• Elevated uric acid levels (hyperuricemia).

Serious Side Effects:

• Severe liver injury.
• Hypersensitivity reactions.
• Potential teratogenic effects (harmful to fetal development).

Precautions:

• Contraindicated in pregnant and breastfeeding women due to potential risks to the fetus and infant.
• Use with caution in patients with gout, liver, or kidney disorders.
• Not recommended for use in children due to lack of sufficient safety and efficacy data

Storage:

• Store at room temperature, below 30°C.
• Keep in a dry place, away from light and moisture.
• Keep out of reach of children.

Conclusion:

Favuza (Favipiravir) 200mg Tablet offers an antiviral option for the management of mild to moderate COVID-19 in adults. While it can aid in reducing viral replication and alleviating symptoms, it is essential to use this medication under the guidance of a healthcare professional, considering potential side effects and contraindications.